28 results
425
LSTA
Lisata Therapeutics Inc
23 Sep 10
Business combination disclosure
12:00am
be substantial disruption to the business of NeoStem and distraction of its workforce and management team.
-38-
The announcement of the Merger may adversely
8-K/A
EX-99.2
LSTA
Lisata Therapeutics Inc
4 Oct 22
Other Events
4:42pm
, and other obligations incident to doing business in another country;
difficulties staffing and managing foreign operations;
workforce uncertainty
8-K
c7j3mehilj4rub39
23 Sep 10
NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
12:00am
425
92mn7h 34g3p
14 Jul 11
Business combination disclosure
12:00am
8-K
u4ub 0n1ssrdrb
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
424B3
70rf22dch8fl3c9
29 Jul 22
Prospectus supplement
4:06pm
424B5
nnj0ia3 okj
16 Nov 10
Prospectus supplement for primary offering
12:00am
424B5
4z5alizmlfrat mqx45
17 Nov 10
Prospectus supplement for primary offering
12:00am